GlobeNewswire
-
Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time
28/04/2026 -
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
28/04/2026 -
BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures
28/04/2026 -
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
28/04/2026 -
Playground Pediatrics Expands Pediatric Access Across Four States
28/04/2026 -
Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
28/04/2026 -
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
28/04/2026 -
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
28/04/2026 -
The Ensign Group Schedules First Quarter 2026 Earnings Call for Friday, May 1, 2026
28/04/2026 -
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
28/04/2026 -
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
28/04/2026 -
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
28/04/2026 -
KFSH Awards Innovation Challenge Winners at C3 Davos of Healthcare™ Silicon Valley Summit
28/04/2026 -
Dr. Petros Kotsidis: KFSH Positions AI as a Scalable Model for Real-World Healthcare Innovation
28/04/2026 -
Dr. Björn Zoëga: Scaling Integrated Digital Systems Will Define the Future of Healthcare
28/04/2026 -
Yinuo Chen, founder of three major Fertility centers—Tulip, ONELIFE, and Sino—was invited to participate in the Shanghai Medical Exhibition
28/04/2026 -
Theolytics Announces First Patient Dosed in the OCTOPOD-IP Trial, a US Phase 1 Trial with THEO-260, a Novel Oncolytic Immunotherapy Targeting Ovarian Cancer
28/04/2026 -
Transactions in connection with share buy-back program
28/04/2026 -
Reacta Healthcare Announces Expansion into Asia-Pacific and Appoints Professor Gary Wing-Kin Wong to Advisory Board
28/04/2026
Pages